Article Details
Retrieved on: 2022-12-20 16:57:07
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
An influential drug pricing research group has cut its suggested price range for Pfizer Inc's COVID-19 antiviral treatment Paxlovid by more than ...
Article found on: www.reuters.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here